CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 146 filers reported holding CASSAVA SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,129 | +1562.4% | 488,502 | +2343.6% | 0.00% | – |
| Q2 2023 | $489 | -37.5% | 19,991 | -38.5% | 0.00% | – |
| Q1 2023 | $783 | -39.3% | 32,501 | -25.6% | 0.00% | -100.0% |
| Q4 2022 | $1,290 | -99.9% | 43,656 | +102.7% | 0.00% | 0.0% |
| Q3 2022 | $901,000 | +55.1% | 21,542 | +4.4% | 0.00% | – |
| Q2 2022 | $581,000 | -35.5% | 20,640 | -14.9% | 0.00% | -100.0% |
| Q1 2022 | $901,000 | -90.7% | 24,261 | -89.1% | 0.00% | -50.0% |
| Q4 2021 | $9,704,000 | +175.3% | 222,016 | +290.9% | 0.00% | 0.0% |
| Q3 2021 | $3,525,000 | +751.4% | 56,801 | +1073.3% | 0.00% | – |
| Q2 2021 | $414,000 | -66.3% | 4,841 | -82.3% | 0.00% | -100.0% |
| Q1 2021 | $1,228,000 | +1605.6% | 27,332 | +157.5% | 0.00% | – |
| Q4 2020 | $72,000 | -41.0% | 10,614 | -0.6% | 0.00% | – |
| Q3 2020 | $122,000 | +34.1% | 10,680 | -63.5% | 0.00% | – |
| Q2 2020 | $91,000 | – | 29,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |